Skip to main content
Cureus logoLink to Cureus
. 2022 Aug 6;14(8):e27733. doi: 10.7759/cureus.27733

The Impact of Migraine Disease on Work Productivity and Quality of Life Among the Adults in Riyadh, Saudi Arabia

Rahaf F Alkahtani 1,, Shawg S Alrumaih 1, Sarah S Algezlan 1, Rahaf R Almutairi 2, Basma A Alturki 3, Raghad M Alanazi 3, Fahad A Alateeq 4
Editors: Alexander Muacevic, John R Adler
PMCID: PMC9444076  PMID: 36106210

Abstract

Background: Migraine is a chronic unilateral headache associated with nausea and vomiting. According to the World Health Organization, it is listed as the 19th disabling disease. Multiple studies found an inverse relationship between the frequency of the attacks and the low quality of life score. Roughly, one-third of migraine attacks occur during workdays, with a higher incidence of reduced productivity and missed days among chronic patients (>15 headache days per month).

Objective: The objective of this article was to determine the migraine impact on work productivity and quality of life in Riyadh's general population in Saudi Arabia.

Materials and methods: A cross-sectional study was conducted among participants suspected or diagnosed with migraine in Riyadh, Saudi Arabia. The survey measured the quality of life with the effect of migraine headaches by the Migraine Specific Quality of Life Questionnaire (MSQ). Patients suspected of migraines were asked to complete the ID Migraine™ three-item screening test.

Results: In this study, we were able to collect data from 223 patients diagnosed with migraine. Among the participants, 99.1% of them were Saudi Arabian, and 93.7% were females. Moreover, 33.6% of the participants were included in the study upon their self-report and 66.4% according to the ID migraine assessment. The mean scores of limitations of the patients’ performance, interrupting normal activities, and emotions were 51.83, 57.11, and 59.94, respectively.

Conclusion: Our study confirmed the results reported in previous studies that migraine has a negative impact on the quality of life of the patients and their ability to work. An awareness program should be conducted to increase the awareness of the importance of the early diagnosis of migraine.

Keywords: quality of life, id migraine™, neurological diseases, work productivity, migraine

Introduction

Migraine is a chronic episodic neurological disease [1]. It presents as unilateral, pulsatile pain associated with nausea and vomiting. The attack’s duration ranges from a minimum of four hours up to a maximum of 72 hours [2,3]. It usually affects the adult age group between 25-55 years [4,5]. Migraine is three times more prevalent among women (18%) when compared to men (6%), which might be related to hormonal imbalance [6,7]. It is estimated to affect 12% of the population worldwide and 26% in Saudi Arabia [8,9]. The majority of migraine attacks are associated with functional impairments [10-12], which induce a negative physical and psychological effect [13]. In fact, Buse et al. found that more than half of the people suffering from migraine need bed rest [11]. Those attacks/consequences ranked migraine as the 19th most disabling disease worldwide according to the World Health Organization [14] resulting in a significantly lower quality of life (QOL) than patients with chronic conditions such as diabetes mellitus, arthritis, and hypertension [15-20]. The QOL was defined by the World Health Organization as “an individual’s perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards, and concerns” [21]. Multiple studies found an inverse relationship between the frequency of the attacks and the low QOL score [19,22,23].

Previous studies showed a positive impact on the QOL in patients with effective migraine therapy [24-27]. However, approximately half of the migraineurs were found to be undiagnosed [24,28], which may contribute to the loss in workers' productivity since no treatment is used. Measuring the QOL and disability is important for determining the burden and management of migraine [9,29]; most of the studies reported the disability by calculating the time lost due to migraine at the workplace, school, or even in doing daily activities [30-34]. Roughly one-third of migraine attacks occur during workdays [35], with a higher incidence of reduced productivity and missed days among chronic (>15 headache days per month) and severe migraine patients (grades III and IV) [29,36]. The estimated average number of missing work due to migraine is four days per year [1], while there is a loss of productivity of 6.7 hours/week per employee [22]. The relation between migraine and decreased work productivity is well-supported in the literature in western countries; however, it is yet to be investigated in our community. Therefore, we aim to investigate the relationship between migraine and work productivity in the population of Riyadh, Saudi Arabia. Assessing the effect of migraine on productivity and determining the factors and triggers of the attacks among the population could aid in increasing the QOL and work productivity by increasing awareness about the treatment options, leading to an improvement in managing the condition.

Materials and methods

This is a cross-sectional study that was conducted among participants who are suspected or diagnosed with migraine by a self-administrated online survey that was published through social media platforms. Participating in the study was completely voluntary, noticing that all participants were informed with consent to join the study before the completion of the questionnaire. The inclusion criteria included patients aged 18 years and above diagnosed with migraine for more than one year or suspected to have migraine and confirmed by the ID Migraine™ questionnaire. Patients with any neurological or cardiovascular disorders and pregnant women were excluded from the study. The sample size was found to be 288 for this cross-sectional study, which is based on a response rate of 50%, a confidence interval of 95%, and a margin of error of 5%. The following formula was used to calculate the sample size:

Sample size = Inline graphic, where Inline graphic is the standard normal variate (5% type 1 error), SD is the standard deviation of the variable, and d is the absolute error.

An adjustment to 300 responses was taken as the sample size to compensate for any missing data or mismatching of the inclusion criteria. This study was approved by the institutional review board (IRB) Ethics Committee of Al Imam Muhammad Ibn Saud University in Riyadh with the approval number of 233/2022.

The survey was divided into the following sections: (1) sociodemographic, including the gender, age, marital status, smoking status, comorbidities, and occupation. Furthermore, an Arabic version of the Migraine Specific Quality of Life Questionnaire (MSQ) was used to measure the QOL with the effect of migraine headaches. It consists of 14 items; the first seven items assess the limitations of migraine on patients’ performance; the next four items assess how it is interrupting normal activities, and the last three items assess the impact of migraine on emotions [37]. Patients that were suspected to have migraine will be asked to complete the ID Migraine™, and a three-item screening test helps to confirm the diagnosis of migraine [38]. 

Microsoft Excel (Microsoft Corporation, Redmond, Washington) was used for data entry, while SPSS software version 26 (IBM Corp., Armonk, NY) was used for data analysis. Frequency and percent were used for the description of categorical variables, while mean and standard deviation were used for the description of the ongoing variables including the subscales of the MSQ tool. To assess the scores of the subscales of MSQ, each response was coded as follows: always as (1) point, almost as (2), pretty as (3), sometimes as (4), rarely (5), and never as (6). For each subscale, a formula was provided by the designers of the questionnaire as follows: For the first subscale of limitation of patients’ performance, the equation is Inline graphic; for interrupting normal activity subscales, the equation is Inline graphic, and for the effect on emotions subscale, the equation is Inline graphic.

T-tests and chi-tests were used to assess the relationship between the demographic factors and MSQ subscales. All statements were considered significant if the p-value is lower or equal to 0.05.

Results

In this study, we were able to collect data from 386 participants for our questionnaire; however, 163 participants were excluded for the next reasons; eight participants refused to participate, three participants were younger than 18 years, 10 patients were pregnant, 22 participants have neurological or cardiovascular conditions, and 102 participants were not diagnosed with migraine using our tool. Among the participants, 99.1% of them were Saudi Arabians, and 93.7% were females. We found that 36.8% of the participants were between 18 and 29 years old, while 30.5% were between 40 and 49 years old, and 17.5% were between 30 and 39 years old. Moreover, we found that 56.5% of the participants were married, while 35.9% were single, and 3.6% of them were smokers. Furthermore, 32.3% of the participants reported that they are governmental employees, while 29.6% were students, and 23.8% were unemployed. Considering the participants having any other chronic disorders, 59.2% indicated having no other chronic disorders, while obesity is reported in 7.2% of them, followed by stress and depression (6.7%) and diabetic mellitus (5.4%). Moreover, 49.3% of the participants reported having a monthly income of lower than 5000 SR (Saudi Riyal); 57.8% reported having university-level education, and 27.8% have secondary school education (Table 1).

Table 1. The demographic factors of the patients (n = 223).

IBS: Irritable bowel syndrome.

  N = 223 %
Nationality Saudi 221 99.1%
Non-Saudi 2 0.9%
Gender Male 14 6.3%
Female 209 93.7%
Age (years) 18-29 82 36.8%
30-39 39 17.5%
40-49 68 30.5%
50-59 29 13.0%
60 and above 5 2.2%
Marital status Single 80 35.9%
Married 126 56.5%
Widow 5 2.2%
Divorced 12 5.4%
Smoking Yes 8 3.6%
No 215 96.4%
Profession Student 66 29.6%
Governmental employee 72 32.3%
Private employee 14 6.3%
In healthcare 4 1.8%
Unemployed 53 23.8%
Retired 14 6.3%
Having chronic disorder No 132 59.2%
IBS 18 8.1%
Diabetic mellitus 12 5.4%
Stress and depression 15 6.7%
Obesity 16 7.2%
Thyroid disorders 0 0.0%
Other 30 13.5%
Monthly income <5000 SR 110 49.3%
6000-10,000 SR 53 23.8%
>10000 SR 60 26.9%
Educational level Intermediate 6 2.7%
Secondary 62 27.8%
Diploma 17 7.6%
University 129 57.8%
Higher education 9 4.0%

In this study, we used two tools for the diagnosis of migraine among the participants; self-reported diagnosis and use of ID Migraine™, where 33.6% of the participants were included in the study upon their self-report and 66.4% according to the ID migraine assessment (Figure 1).

Figure 1. The distribution of the patients according to the diagnosis criteria.

Figure 1

Moreover, 13.9% of the participants were diagnosed with migraine more than five years ago, and 9% were diagnosed three to five years ago. The MSQ assesses the QOL across three subscales: limitations of patients’ performance, interrupting normal activities, and emotions with a scale between 0% and 100% where a higher score indicated better QOL. The mean of the three subscales among the total sample were 51.83, 57.11, and 59.94, respectively. According to Table 2, we found that gender had no significant impact on the QOL because of migraine; however, females reported slightly better QOL on all scales (p = 0.836, 0.621, and 0.651). Moreover, we found that younger participants had the least QOL considering the effect of migraine on their emotions (p = 0.001). Also, the most common effect of migraine on emotions was found among widow patients (p = 0.001). Smoking was the only factor that affects the three subscales of the QOL of patients with migraine where smokers reported lower QOL in all aspects than non-smokers. Moreover, the profession of the patients has a significant effect on the impact of migraine on the emotions subscale where retired patients showed the highest QOL. The education level of the patients has no effect on the QOL of the patients with migraine (Table 2).

Table 2. The quality of life among the patients with migraine using Migraine Specific Quality of Life Questionnaire and their demographic factors.

* p-value ≤ 0.05.

  Limitations on patients’ performance Interrupting normal activities Emotions
Mean of the total sample 51.83 57.11 59.94
Gender Male 50.41 53.57 56.67
Female 51.93 57.34 60.16
P-value 0.836 0.621 0.651
Age (years) 18-29 51.11 59.57 51.06
30-39 47.03 53.21 59.66
40-49 51.47 54.85 64.22
50-59 59.51 58.28 73.56
60 and above 61.71 71.00 70.67
P-value 0.349 0.525 0.001*
Marital status Single 49.71 58.06 49.83
Married 53.38 56.55 65.08
Widow 53.71 66.00 77.33
Divorced 49.05 52.92 66.11
P-value 0.781 0.816 0.000*
Smoking Yes 33.21 34.38 40.00
No 52.53 57.95 60.68
P-value 0.043* 0.017* 0.039*
Profession Student 48.10 58.41 48.28
Governmental employee 51.98 55.42 62.41
Private employee 47.76 53.21 68.10
In healthcare 61.43 62.50 61.67
Unemployed 54.99 58.21 65.16
Retired 58.16 57.86 73.81
P-value 0.596 0.968 0.002*
Monthly income <5000 SR 50.26 57.50 53.82
6000-10,000 SR 51.91 53.87 65.41
>10000 SR 54.67 59.25 66.33
P-value 0.588 0.574 0.005*
Educational level Intermediate 52.38 46.67 67.78
Secondary 50.88 58.06 51.51
Diploma 54.29 54.71 59.22
University 51.89 57.95 63.88
Higher education 52.70 50.00 57.78
P-value 0.994 0.778 0.065

Discussion

Many previous studies have shown that migraine patients experience a lower QOL than the general population, and the attack frequency is inversely related to QOL score [17,19]. Moreover, some studies also showed that the effective treatment of migraine has a positive effect on health-related QOL [24-27]. The aim of this study was to investigate the relationship between migraine and work productivity in the population of Riyadh, Saudi Arabia.

In this study, we included 223 patients with migraine where 33.6% were from patients’ reports and 66.4% according to the ID migraine assessment. The ID migraine assessment tool consisted of three questions where only participants who answered "Yes" for two or three questions were diagnosed with migraine and included in the study, while those who answered "Yes" for one question or "No" for the three questions were excluded from the study. This indicates that 66.4% of patients with migraine did not know that they had migraine or did not tend to physicians in order to have a correct diagnosis. The ID migraine assessment is a validated questionnaire for the diagnosis of migraine [38]. In a previous study conducted among employees in two different banks, the authors found that 47.2% of them were diagnosed with migraine using the ID migraine assessment tool [39]. Our results are similar to the results reported in European countries where migraine is one of the conditions which remains underdiagnosed [40]. These findings ensure the need to increase the awareness of public populations with recurrent headaches to seek appropriate diagnosis and, hence, care [40].

In this study, we found that patients with migraine were mostly females and those aged between 30 and 49 years. Similar results had been reported in a previous study which showed that the prevalence of migraine peaks at their prime working age (31-40 years) [41]. The reason for the high prevalence of migraine during this period is that career and family responsibilities started to appear. This is typically most crucial and implies that migraines not only pose immense economic burdens on the patients but also had a negative impact on the harmony of the patients’ social and family life. Moreover, similar to this study, a higher prevalence of migraine among females compared to males is also reported in some other studies [41,42]. The reason for the high prevalence of migraine among females compared to males is the difference in the physiological and hormonal influences [42]. This result suggests the need for a gender-based strategy to promote the prevention and care of migraine risks.

The present study showed that migraine has a substantial negative impact on participants’ QOL and ability to work. The mean of the three subscales, limitations of patients’ performance, interrupting normal activities, and emotions, among the total sample, was 51.83, 57.11, and 59.94, respectively. This is consistent with other research [34]. This clearly demonstrates that migraine caused impairments in work productivity and resulted in a substantial occupational disability. In a previous study conducted among healthcare workers in primary healthcare centers in Abha, Saudi Arabia, via self-administered questionnaires such as Migraine Disability Assessment (MIDAS) and World Health Organization Quality of Life (WHOQOL-BREF), the authors found that MIDAS Mean ± SD was 12 ± 10.6, and 54.9 ± 7.4 for health-related quality of life (HRQOL), and the authors also found that smoking was significantly associated with HRQOL (p = 0.037), which is similar to our results where smoking is the only factor that affects the QOL among patients [43]. Smoking has a negative impact on the QOL even among normal populations. Non-smokers had an average probability of having a higher QOL than smokers [44]. Moreover, lower QOL and higher prevalence of depression were associated with higher odds of smoking initiation and lower odds of successful smoking cessation [45]. A study conducted by Alharbi and AlAteeq showed that the mean scores of the QOL restrictive, preventive, and emotional domains were 51.8 ± 19, 54 ± 18, and 46.3 ± 23.4, respectively, which is quite similar to our results [9]. However, the same study showed that decreased QOL scores were especially seen among young patients, patients with repeated migraine attacks, patients who do not use prophylactic treatment, and individuals diagnosed with a chronic disease [9].

This study had some limitations including dependence on a self-report questionnaire for the diagnosis of migraine, which may lead to some personal bias. Moreover, depending on the self-reported tool for the diagnosis of migraine could not be used without clinical examinations and diagnosis. Therefore, we suggest that further investigations depending on clinical examination are required. 

Conclusions

In conclusion, our study confirmed the results reported in previous studies that migraine has a negative impact on the QOL of the patients and their ability to work. Therefore, awareness programs should be conducted to increase the awareness of the importance of the early diagnosis of migraine.

Appendices

Table 3. Questionnaire.

Demographic factors
1) Age (years)
<18
18-29
30-39
40-49
50-59
60+
2) Nationality
Saudi
Non-Saudi
3) Gender
Female
Male
4) What is your marital status?
Single
Married
Divorced
Widowed
5) If married, are you pregnant?
Yes
No
6) Do you smoke?
Yes
No
7) What is your occupation?
Student
Healthcare sector
Student
Healthcare sector
Government sector
Freelance
Retired
Unemployed
Others
8) Do you have any chronic diseases?
Cardiovascular diseases
Neurological diseases
Hypertension
Diabetes
Obesity
Thyroid disorders
Depression
Anxiety
Irritable bowel syndrome
Others
None
9) Which of these describe your personal income?
5000 SR or less
6000–10000 SR
11000 and more SR
10) What is the highest degree or level of education you have completed?
No education
Elementary
Intermediate
High school
Diploma
University
Master’s degree or higher
11) Are you diagnosed with migraine? Yes or no
12) If yes, for how long are you diagnosed with migraine?
Less than 12 months
1-2 years
3-5 years
More than 5 years
If not diagnosed with migraine, please answer the following screening test: During the last three months, did you have the following with your headache?
13) You felt nauseated or sick to your stomach?
Yes
No
14) Light bothered you (a lot more when you didn’t have headaches)?
Yes
No
15) Your headaches limited your ability to work study or do what you need to do for at least one day?
Yes
No
MSQ: Migraine Specific Quality of Life Questionnaire
While answering the following questions, please think about all migraine attacks you may have had in the past four weeks.
16) How often have migraines interfered with how well you dealt with family, friends, and others who are close to you?
Always
Almost
Pretty
Sometimes
Rarely
Never
17) How often have migraines interrupted with your leisure time activities such as reading or exercising?
Always
Almost
Pretty
Sometimes
Rarely
Never
18) How often have you had difficulty in performing work or other daily activities?
Always
Almost
Pretty
Sometimes
Rarely
Never
19) How often have migraines kept you from getting as much accomplished as you normally do at work or at home?
Always
Almost
Pretty
Sometimes
Rarely
Never
20) How often have migraines limited your ability to work or do other activities as carefully as you usually do them?
Always
Almost
Pretty
Sometimes
Rarely
Never
21) How often have you had to cancel or delay work or social activities because you were exhausted?
Always
Almost
Pretty
Sometimes
Rarely
Never
22) How often have migraines left you with limited energy levels?
Always
Almost
Pretty
Sometimes
Rarely
Never
23) How often have you had to stop work or other activities?
Always
Almost
Pretty
Sometimes
Rarely
Never
24) How often have you needed the help of other people in handling routine tasks such as everyday household chores, doing necessary business, shopping, or caring for others when you had a migraine attack?
Always
Almost
Pretty
Sometimes
Rarely
Never
25) How often have you avoided social or family activities to treat your migraine attacks?
Always
Almost
Pretty
Sometimes
Rarely
Never
26) How often has it been difficult for you to go to social events such as parties?
Always
Almost
Pretty
Sometimes
Rarely
Never
27) How often have you felt fed up or frustrated?
Always
Almost
Pretty
Sometimes
Rarely
Never
28) How often have you felt like you were a burden on others?
Always
Almost
Pretty
Sometimes
Rarely
Never
29) How often have you been afraid of letting others down?
Always
Almost
Pretty
Sometimes
Rarely
Never

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study. Al Imam Muhammad Ibn Saud Islamic University issued approval 233/2022

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. Burton WN, Landy SH, Downs KE, Runken MC. Mayo Clin Proc. 2009;84:436–445. doi: 10.1016/S0025-6196(11)60562-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Age-dependent prevalence and clinical features of migraine. Bigal ME, Liberman JN, Lipton RB. Neurology. 2006;67:246–251. doi: 10.1212/01.wnl.0000225186.76323.69. [DOI] [PubMed] [Google Scholar]
  • 3.Prevalence of and factors associated with migraine in medical students at BandarAbbas, Southern Iran, in 2012. Yazdanparast M, Abrishamizadeh AA, Mahboobi H, et al. Electron Physician. 2013;5:679–684. doi: 10.14661/2013.679-684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Impact of migraine in the United States: data from the National Health Interview Survey. Stang PE, Osterhaus JT. Headache. 1993;33:29–35. doi: 10.1111/j.1526-4610.1993.hed3301029.x. [DOI] [PubMed] [Google Scholar]
  • 5.Burden of migraine: societal costs and therapeutic opportunities. Lipton RB, Stewart WF, von Korff M. Neurology. 1997;48:0–9. doi: 10.1212/wnl.48.3_suppl_3.4s. [DOI] [PubMed] [Google Scholar]
  • 6.Migraine in the United States: epidemiology and patterns of health care use. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Neurology. 2002;58:885–894. doi: 10.1212/wnl.58.6.885. [DOI] [PubMed] [Google Scholar]
  • 7.The prevalence of migraine and probable migraine in a Brazilian favela: results of a community survey. Lucchetti G, Peres MF. Headache. 2011;51:971–979. doi: 10.1111/j.1526-4610.2011.01899.x. [DOI] [PubMed] [Google Scholar]
  • 8.Migraine prevalence, disease burden, and the need for preventive therapy. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Neurology. 2007;68:343–349. doi: 10.1212/01.wnl.0000252808.97649.21. [DOI] [PubMed] [Google Scholar]
  • 9.Quality of life of migraine patients followed in neurology clinics in Riyadh, Saudi Arabia. AlHarbi FG, AlAteeq MA. J Family Community Med. 2020;27:37–45. doi: 10.4103/jfcm.JFCM_185_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF) Leonardi M, Steiner TJ, Scher AT, Lipton RB. J Headache Pain. 2005;6:429–440. doi: 10.1007/s10194-005-0252-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Buse DC, Rupnow MF, Lipton RB. Mayo Clin Proc. 2009;84:422–435. doi: 10.1016/S0025-6196(11)60561-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Migraine and functional impairment. Brandes JL. CNS Drugs. 2009;23:1039–1045. doi: 10.2165/11530030-000000000-00000. [DOI] [PubMed] [Google Scholar]
  • 13.The impact of migraine on the health and well-being of women. Diamond M. J Womens Health (Larchmt) 2007;16:1269–1280. doi: 10.1089/jwh.2007.0388. [DOI] [PubMed] [Google Scholar]
  • 14.Aretaeus on migraine and headache. Koehler PJ, van de Wiel TW. J Hist Neurosci. 2001;10:253–261. doi: 10.1076/jhin.10.3.253.9089. [DOI] [PubMed] [Google Scholar]
  • 15.Towards an objective quantitative assessment of daily functioning in migraine: a feasibility study. Tulen JHM, Stronks DL, Bussmann JBJ, Pepplinkhuizen L, Passchier J. Pain. 2000;86:139–149. doi: 10.1016/s0304-3959(00)00235-9. [DOI] [PubMed] [Google Scholar]
  • 16.[Migraine prevalence and impact in employees of the clinical hospital of the medical school of Ribeirão Preto-USP] Bigal ME, Fernandes LC, Moraes FA, Bordini CA, Speciali JG. Arq Neuropsiquiatr. 2000;58:431–436. doi: 10.1590/s0004-282x2000000300007. [DOI] [PubMed] [Google Scholar]
  • 17.Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF. Cephalalgia. 2003;23:441–450. doi: 10.1046/j.1468-2982.2003.00546.x. [DOI] [PubMed] [Google Scholar]
  • 18.Migraine frequency and intensity: relationship with disability and psychological factors. Magnusson JE, Becker WJ. Headache. 2003;43:1049–1059. doi: 10.1046/j.1526-4610.2003.03206.x. [DOI] [PubMed] [Google Scholar]
  • 19.The impact of migraine on quality of life in the general population: the GEM study. Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ. Neurology. 2000;55:624–629. doi: 10.1212/wnl.55.5.624. [DOI] [PubMed] [Google Scholar]
  • 20.Measuring the functional status and well-being of patients with migraine headache. Osterhaus JT, Townsend RJ, Gandek B, Ware JE Jr. Headache. 1994;34:337–343. doi: 10.1111/j.1526-4610.1994.hed3406337.x. [DOI] [PubMed] [Google Scholar]
  • 21.WHOQOL. Nakane Y, Tazaki M, Miyaoka E, et al. Iryo To Shakai. 1999;9:123–131. [Google Scholar]
  • 22.Productivity losses attributable to headache, and their attempted recovery, in a heavy-manufacturing workforce in Turkey: implications for employers and politicians. Selekler HM, Gökmen G, Alvur TM, Steiner TJ. J Headache Pain. 2015;16:96. doi: 10.1186/s10194-015-0579-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.My migraine voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. Martelletti P, Schwedt TJ, Lanteri-Minet M, et al. J Headache Pain. 2018;19:115. doi: 10.1186/s10194-018-0946-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine. Mushet GR, Miller D, Clements B, Pait G, Gutterman DL. Headache. 1996;36:137–143. doi: 10.1046/j.1526-4610.1996.3603137.x. [DOI] [PubMed] [Google Scholar]
  • 25.Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes. Cohen JA, Beall D, Beck A, et al. Clin Ther. 1999;21:190–204. doi: 10.1016/S0149-2918(00)88278-8. [DOI] [PubMed] [Google Scholar]
  • 26.Improvements in health-related quality of life with sumatriptan treatment for migraine. Jhingran P, Cady RK, Rubino J, Miller D, Grice RB, Gutterman DL. http://www.ncbi.nlm.nih.gov/pubmed/8537803. J Fam Pract. 1996;42:36–42. [PubMed] [Google Scholar]
  • 27.Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective. Lofland JH, Johnson NE, Batenhorst AS, Nash DB. Arch Intern Med. 1999;159:857–863. doi: 10.1001/archinte.159.8.857. [DOI] [PubMed] [Google Scholar]
  • 28.Migraine diagnosis and treatment: results from the American migraine study II. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Headache. 2001;41:638–645. doi: 10.1046/j.1526-4610.2001.041007638.x. [DOI] [PubMed] [Google Scholar]
  • 29.Quality of life and migraine disability among female migraine patients in a tertiary hospital in Malaysia. Shaik MM, Hassan NB, Tan HL, Gan SH. Biomed Res Int. 2015;2015:523717. doi: 10.1155/2015/523717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Healthcare resource and lost labour costs of migraine headache in the US. Osterhaus JT, Gutterman DL, Plachetka JR. Pharmacoeconomics. 1992;2:67–76. doi: 10.2165/00019053-199202010-00008. [DOI] [PubMed] [Google Scholar]
  • 31.Work-related disability: results from the American migraine study. Stewart WF, Lipton RB, Simon D. Cephalalgia. 1996;16:231–238. doi: 10.1046/j.1468-2982.1996.1604231.x. [DOI] [PubMed] [Google Scholar]
  • 32.Loss of productivity and quality of life in migraine sufferers among French workers: results from the GAZEL cohort. Michel P, Dartigues JF, Lindoulsi A, Henry P. Headache. 1997;37:71–78. doi: 10.1046/j.1526-4610.1997.3702071.x. [DOI] [PubMed] [Google Scholar]
  • 33.Migraine and reduced work performance: a population-based diary study. Von Korff M, Stewart WF, Simon DJ, Lipton RB. Neurology. 1998;50:1741–1745. doi: 10.1212/wnl.50.6.1741. [DOI] [PubMed] [Google Scholar]
  • 34.Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Can J Neurol Sci. 1993;20:131–137. doi: 10.1017/s0317167100047697. [DOI] [PubMed] [Google Scholar]
  • 35.Work impact of migraine headaches. Stewart WF, Wood GC, Razzaghi H, Reed ML, Lipton RB. J Occup Environ Med. 2008;50:736–745. doi: 10.1097/JOM.0b013e31818180cb. [DOI] [PubMed] [Google Scholar]
  • 36.Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Munakata J, Hazard E, Serrano D, et al. Headache. 2009;49:498–508. doi: 10.1111/j.1526-4610.2009.01369.x. [DOI] [PubMed] [Google Scholar]
  • 37.Migraine-specific quality of life questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine. Chang HY, Jensen MP, Yang CC, Lai YH. Health Qual Life Outcomes. 2019;17:108. doi: 10.1186/s12955-019-1169-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.A self-administered screener for migraine in primary care: the ID migraine validation study. Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W. Neurology. 2003;61:375–382. doi: 10.1212/01.wnl.0000078940.53438.83. [DOI] [PubMed] [Google Scholar]
  • 39.Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia. Wong LP, Alias H, Bhoo-Pathy N, Chung I, Chong YC, Kalra S, Shah ZU. J Headache Pain. 2020;21:68. doi: 10.1186/s10194-020-01144-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.What is the impact of physician communication and patient understanding in the management of headache? Patwardhan M, Coeytaux RR, Deshmukh R, Samsa G. Neuropsychiatr Dis Treat. 2007;3:893–897. doi: 10.2147/ndt.s493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.The economic burden of lost productivity due to migraine headache: a specific worksite analysis. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. J Occup Environ Med. 2002;44:523–529. doi: 10.1097/00043764-200206000-00013. [DOI] [PubMed] [Google Scholar]
  • 42.Sex matters: evaluating sex and gender in migraine and headache research. Peterlin BL, Gupta S, Ward TN, Macgregor A. Headache. 2011;51:839–842. doi: 10.1111/j.1526-4610.2011.01900.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Prevalence, determinants and impact of migraine on quality of life of healthcare workers at primary healthcare centers in Abha City, Saudi Arabia. Alfaifi FJS, Qasim MY, Al-Harban AM, Alqahtani SSA, Alshahrani NMS. https://web.p.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=14484196&AN=151730348&h=t7EsLmwyJPU2zdqPPLBcbLfjCCN1duoU7Mx1RmKXmb78rIL2kDNRs%2flDq8NNy75N8AgHfSQexw4Lh1zKqP4BYw%3d%3d&crl=c&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26jrnl%3d14484196%26AN%3d151730348 Middle East J Fam Med. 2021;19:122–136. [Google Scholar]
  • 44.The association between smoking and health-related quality of life among Chinese individuals aged 40 years and older: a cross-sectional study. Cheng X, Jin C. Front Public Health. 2022;10:779789. doi: 10.3389/fpubh.2022.779789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Quality of life and smoking. Goldenberg M, Danovitch I, IsHak WW. Am J Addict. 2014;23:540–562. doi: 10.1111/j.1521-0391.2014.12148.x. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES